An observational study in Acute Pancreatitis, sponsored by University of Regensburg. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-08-09.
Sponsored by University of Regensburg · Observational
The study aims to evaluate the course of patients with acute pancreatitis. Thereby we analyze different diagnostics and compare ultrasound, MRI and CT-scan in detection of necrotic areas and evaluate interventional therapy methods like percutaneous drainage techniques regarding the outcome. Laboratory values were assessed as well.
For laboratory values different inflammation markers were measured and compared.
759 studies on the registry are indexed under Pancreatitis; 181 are open to participants now.
This study's planned enrollment of 50 is below the median of 179 across 282 observational studies indexed under Pancreatitis.
Browse Pancreatitis studies →University of Regensburg is the lead sponsor of 71 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
50 patients with acute pancreatitis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Evaluation of one study cohort
Other: CT-guided percutaneous drainage technique
Evaluation of different diagnostics and evaluation of outcome of patients who received percutaneous CT-guided drainage for necrotic debridement and analyze the further outcome
Length of hospital stay
Time frame: weekly
time to surgery
Time frame: weekly
active necrosectomy
Time frame: weekly
ICU stay
Time frame: weekly
This study is status unknown, as verified in Jun 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Regensburg